Neoplasms by Site Completed Phase 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00050414A Study of Trabectedin in Patients With Advanced Ovarian CancerTreatment